Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
Authors
Keywords
Aspergillus, Coronavirus disease 2019, Coronavirus disease 2019-associated pulmonary aspergillosis, Intensive care unit, Survival
Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-26
DOI
10.1016/j.cmi.2021.08.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series
- (2021) Eelco F. J. Meijer et al. MYCOSES
- Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches
- (2021) Jeffrey D. Jenks et al. MYCOSES
- Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
- (2021) Lore Vanderbeke et al. INTENSIVE CARE MEDICINE
- Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
- (2021) Juergen Prattes et al. INTENSIVE CARE MEDICINE
- COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
- (2021) Juergen Prattes et al. INTENSIVE CARE MEDICINE
- Aspergillus fumigatus and aspergillosis: From basics to clinics
- (2021) A. Arastehfar et al. STUDIES IN MYCOLOGY
- COVID-19 Associated Pulmonary Aspergillosis
- (2020) Andreas L.E. van Arkel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- COVID‐19 associated pulmonary aspergillosis
- (2020) Philipp Koehler et al. MYCOSES
- Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
- (2020) Alexandre Alanio et al. Lancet Respiratory Medicine
- Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study
- (2020) Michele Bartoletti et al. CLINICAL INFECTIOUS DISEASES
- Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
- (2020) T. Lahmer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
- (2020) Paul E. Verweij et al. INTENSIVE CARE MEDICINE
- COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: An observational study from Pakistan
- (2020) Nosheen Nasir et al. MYCOSES
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Bronchoscopy safety precautions for diagnosing COVID‐19 associated pulmonary aspergillosis—A simulation study
- (2020) Philipp Koehler et al. MYCOSES
- Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
- (2020) Philipp Koehler et al. LANCET INFECTIOUS DISEASES
- Prevalence of opportunistic invasive aspergillosis in COVID‐19 patients with severe pneumonia
- (2020) Gonzalo Segrelles‐Calvo et al. MYCOSES
- Invasive pulmonary aspergillosis in the COVID‐19 era: An expected new entity
- (2020) Marina Machado et al. MYCOSES
- The human lung and Aspergillus: You are what you breathe in?
- (2018) Malcolm Richardson et al. MEDICAL MYCOLOGY
- FungiScope™ -Global Emerging Fungal Infection Registry
- (2017) Danila Seidel et al. MYCOSES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started